Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 215   

Articles published

SNY 44.33 +0.08 (0.18%)
price chart
Sanofi SA (ADR)'s Trend Up, Especially After Today's Gap Up
The stock of Sanofi SA (ADR) (NYSE:SNY) gapped up by $0.29 today and has $59.74 target or 35.00% above today's $44.25 share price.
Here is What Hedge Funds Think About Sanofi SA (ADR) (SNY)
Is Sanofi SA (ADR) (NYSE:SNY) a splendid investment now? Money managers are in a slightly bearish mood as the number of bullish hedge fund positions retreated by 1 in recent months.
Google Inc, Sanofi SA (ADR) Partner Up For Diabetes Research
The Wall Street Journal has reported that Google Inc. (NASDAQ:GOOG) is going to partner up with European pharmaceutical giant Sanofi SA (NYSE:SNY) to research on monitoring and curing diabetes. While both the companies refused to disclose how ...
Google, Sanofi join forces on Diabetes monitoring and treatment  MarketWatch
Sanofi Teams Up with Google Life Sciences for Diabetes
Regeneron Pharmaceuticals Inc And Sanofi SA (ADR) Win EU Nod For Cholesterol ...
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), a leader in the biotech sector, and Sanofi SA (ADR) (NYSE:SNY), the French pharmaceutical giant, have fetched a victory adding to their success in the pharmaceutical sector.
Company Update (NASDAQ:REGN): Regeneron Pharmaceuticals Inc and Sanofi SA ...  Smarter Analyst
A Reversal for Sanofi SA (ADR) Is Not Near. The Stock Declines Again
The stock of Sanofi SA (ADR) (NYSE:SNY) is a huge mover today! The stock is down 0.45% or $0.2 after the news, hitting $43.99 per share.
European Stocks to Focus: Unilever N.V. (ADR) (NYSE:UN), Sanofi SA (ADR ...  News Oracle
Sanofi SA (ADR) Scouts For New Cancer Treatments That Harness Immune Cells
Pharmaceutical giant Sanofi is partnering with two biotech companies -- Evotec AG in Hamburg, Germany, and Apeiron Biologics AG in Vienna, Austria - in its latest effort to develop a drug that harnesses the body's own immune system in the fight against ...
Sanofi Inks Deals, Diabetes and Immuno-Oncology in Focus
European Equities for Your Trading Radar: GlaxoSmithKline plc (ADR) (GSK ...
European stocks moved higher and oil prices reversed course and fell 1 percent on Wednesday as investors' concerns eased over the potential fallout of Turkey's shooting down of a Russian fighter jet.
EPS for Sanofi SA (ADR) (SNY) to Rise
Analysts await Sanofi SA (ADR) (NYSE:SNY) to reports earnings on October, 29 before the open. They expect $0.90 earnings per share, down 4.26% or $0.04 from last year's $0.94 per share.
Buzz Stocks: MGM Resorts International, Allergan PLC, and Sanofi SA (ADR)
Sanofi SA believes that its sales of Lantus insulin will fall between 4% and 8% through 2018. Technically, the stock has fallen 11.7% since mid-August's high of $54.98, and is now set to end beneath its 10-day and 20-day moving averages for the first ...
Bayer's Brandicourt To Be Named Sanofi SA (ADR) CEO - Reports
Sanofi SA (ADR) (NYSE:SNY) has been searching for a candidate to replace its ousted Chief Executive Officer Chris Viehbacher ever since October last year; Olivier Brandicourt, head of Bayer AG (ADR)'s (OTCMKTS:BAYRY) healthcare business, might put ...